These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 15343213)
21. Prescriptions for vitamin D among patients taking antiresorptive agents in Canada. Hanley DA; Zhang Q; Meilleur MC; Mavros P; Sen SS Curr Med Res Opin; 2007 Jun; 23(6):1473-80. PubMed ID: 17559742 [TBL] [Abstract][Full Text] [Related]
22. Content and format of labeling for human prescription drugs; pregnancy labeling; public hearing--FDA. Notice of public hearing; request for comments. Fed Regist; 1997 Jul; 62(147):41061-3. PubMed ID: 10169832 [TBL] [Abstract][Full Text] [Related]
23. Use of over-the-counter medications and herbal remedies in pregnancy. Refuerzo JS; Blackwell SC; Sokol RJ; Lajeunesse L; Firchau K; Kruger M; Sorokin Y Am J Perinatol; 2005 Aug; 22(6):321-4. PubMed ID: 16118721 [TBL] [Abstract][Full Text] [Related]
24. Drug use by pregnant women and comparable non-pregnant women in The Netherlands with reference to the Australian classification system. Schirm E; Meijer WM; Tobi H; de Jong-van den Berg LT Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):182-8. PubMed ID: 15140513 [TBL] [Abstract][Full Text] [Related]
25. Food fortification with folic acid and rate of multiple births, 1994-2000. Lawrence JM; Watkins ML; Chiu V; Erickson JD; Petitti DB Birth Defects Res A Clin Mol Teratol; 2004 Dec; 70(12):948-52. PubMed ID: 15562514 [TBL] [Abstract][Full Text] [Related]
26. Tuberculosis and pregnancy--Results of a study in a high prevalence area in London. Kothari A; Mahadevan N; Girling J Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):48-55. PubMed ID: 16154251 [TBL] [Abstract][Full Text] [Related]
27. Increasing exposure to angiotensin-converting enzyme inhibitors in pregnancy. Bowen ME; Ray WA; Arbogast PG; Ding H; Cooper WO Am J Obstet Gynecol; 2008 Mar; 198(3):291.e1-5. PubMed ID: 18191803 [TBL] [Abstract][Full Text] [Related]
28. Association between change of health care providers and pregnancy exposure to FDA category C, D and X drugs. Yang J; Xie R; Krewski D; Wang Y; Walker M; Cao W; Wen SW Chin Med J (Engl); 2014; 127(4):702-6. PubMed ID: 24534226 [TBL] [Abstract][Full Text] [Related]
29. Uterine fibroid treatment patterns in a population of insured women. Lee DW; Gibson TB; Carls GS; Ozminkowski RJ; Wang S; Stewart EA Fertil Steril; 2009 Feb; 91(2):566-74. PubMed ID: 18304543 [TBL] [Abstract][Full Text] [Related]
30. Postmarketing surveillance for drug safety in pregnancy: the Organization of Teratology Information Services project. Felix RJ; Jones KL; Johnson KA; McCloskey CA; Chambers CD; Birth Defects Res A Clin Mol Teratol; 2004 Dec; 70(12):944-7. PubMed ID: 15570610 [TBL] [Abstract][Full Text] [Related]
31. Health service use and outcomes among disabled Medicaid pregnant women. Gavin NI; Benedict MB; Adams EK Womens Health Issues; 2006; 16(6):313-22. PubMed ID: 17188214 [TBL] [Abstract][Full Text] [Related]
32. A pharmacoepidemiological approach to investigating inappropriate physician prescribing in a managed care setting in Israel. Kahan NR; Blackman S; Kutz C; Waitman DA Am J Manag Care; 2005 Feb; 11(2):89-90. PubMed ID: 15726856 [TBL] [Abstract][Full Text] [Related]
33. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program. Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145 [TBL] [Abstract][Full Text] [Related]
34. Pregnancy in women who have epilepsy. Pennell PB Neurol Clin; 2004 Nov; 22(4):799-820. PubMed ID: 15474768 [TBL] [Abstract][Full Text] [Related]
35. An assessment of mother-to-child HIV transmission prevention in 16 pilot antenatal clinics in Jamaica. Harvey KM; Figueroa JP; Tomlinson J; Gebre Y; Forbes S; Toyloy T; Thompson T; Thompson K West Indian Med J; 2004 Oct; 53(5):293-6. PubMed ID: 15675493 [TBL] [Abstract][Full Text] [Related]
36. Cesarean section on request at 39 weeks: impact on shoulder dystocia, fetal trauma, neonatal encephalopathy, and intrauterine fetal demise. Hankins GD; Clark SM; Munn MB Semin Perinatol; 2006 Oct; 30(5):276-87. PubMed ID: 17011400 [TBL] [Abstract][Full Text] [Related]
37. Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organization. Cooke CE; Hammerash WJ Clin Ther; 2006 Apr; 28(4):591-9. PubMed ID: 16750470 [TBL] [Abstract][Full Text] [Related]
38. [Drug prescription for pregnant women: a pharmacoepidemiological study]. Carmo TA; Nitrini SM Cad Saude Publica; 2004; 20(4):1004-13. PubMed ID: 15300293 [TBL] [Abstract][Full Text] [Related]
39. FDA drug prescribing warnings: is the black box half empty or half full? Wagner AK; Chan KA; Dashevsky I; Raebel MA; Andrade SE; Lafata JE; Davis RL; Gurwitz JH; Soumerai SB; Platt R Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):369-86. PubMed ID: 16294363 [TBL] [Abstract][Full Text] [Related]
40. Drug intake behaviour of immigrants during pregnancy. Checa MA; Peiró R; Pascual J; Carreras R Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):38-45. PubMed ID: 15936867 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]